Home / XTREME GAMERZ PRO / 23andMe, GlaxoSmithKline deal raising concerns over privacy

23andMe, GlaxoSmithKline deal raising concerns over privacy


23andMe, GlaxoSmithKline deal raising concerns over privacy



Fox News medical correspondent Dr. Marc Siegel on the promising signs in Biogen's Alzheimer's new treatment, GlaxoSmithKline buying a stake in 23andMe and the potential privacy concerns over the genetic service.

23andMe, GlaxoSmithKline deal raising concerns over privacy 23andMe, GlaxoSmithKline deal raising concerns over privacy Reviewed by SUJAL PANDHARE on July 26, 2018 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.